Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kouichi, Tatsuta"'
Autor:
Mitsuru Yashiro, Tomohiro Sonou, Takurou Yano, Toru Mima, Kazuki Kawakami, Kouichi Tatsuta, Sou Kobayashi, Yusuke Tanaka, Yuri Nakashima, Shuto Yamamoto, Takashi Shigematsu, Shigeo Negi, Masaki Ohya
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 182:113139
Osteocytes play an important role in the regulation of serum phosphorus by producing fibroblast growth factor 23 (FGF23). FGF23 production is stimulated by 1α,25-dihydroxyvitamin D in osteocytes. However, it is unclear whether vitamin D induces FGF2
Autor:
Masaki, Ohya, Mitsuru, Yashiro, Tomohiro, Sonou, Kouji, Okuda, Kouichi, Tatsuta, Toru, Mima, Yoshinori, Tone, Shigeo, Negi, Yasushi, Saika, Takashi, Shigematsu
Publikováno v:
Contributions to nephrology. 196
Fibroblast growth factor 23 (FGF23) is a regulator of phosphate and vitamin D homeostasis that carries out primary bone- and mineral-related physiological functions to increase renal phosphate excretion and reduce 1α-hydroxylation of 25-hydroxyvitam
Autor:
Takashi Shigematsu, Kouichi Tatsuta, Mitsuru Yashiro, Shigeo Negi, Ishizawa Yohei, Yuko Iwashita, Masaki Ohya, Takurou Yano, Shuto Yamamoto, Yusuke Tanaka, Sou Kobayashi, Toru Mima, Ryo Matoba, Tomohiro Shoshihara, Yuri Nakashima, Yu Iwashita, Kazuki Kawakami, Ueda Yumi, Tomohiro Sonou, Kouji Okuda
Publikováno v:
International Journal of Nephrology and Renovascular Disease
Mitsuru Yashiro,1 Masaki Ohya,1 Toru Mima,1 Yumi Ueda,2 Yuri Nakashima,1 Kazuki Kawakami,1 Yohei Ishizawa,2 Shuto Yamamoto,1 Sou Kobayashi,1 Takurou Yano,1 Yusuke Tanaka,1 Kouji Okuda,1 Tomohiro Sonou,1 Tomohiro Shoshihara,1 Yuko Iwashita,1 Yu Iwashi
Autor:
Masaki Ohya, Kouichi Tatsuta, Tomohiro Sonou, Kouji Okuda, Shigeo Negi, Yoshinori Tone, Yasushi Saika, Toru Mima, Takashi Shigematsu, Mitsuru Yashiro
Fibroblast growth factor 23 (FGF23) is a regulator of phosphate and vitamin D homeostasis that carries out primary bone- and mineral-related physiological functions to increase renal phosphate excretion and reduce 1α-hydroxylation of 25-hydroxyvitam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::257ece01c22b73eed94fe3cf98facf22
https://doi.org/10.1159/000485696
https://doi.org/10.1159/000485696
Autor:
Takashi, Shigematsu, Masaki, Ohya, Shigeo, Negi, Asuka R, Masumoto, Yuri M, Nakashima, Yuka, Iwatani, Mari K, Moribata, Shintaro, Yamanaka, Kouichi, Tatsuta, Toru, Mima
Publikováno v:
Contributions to nephrology. 185
In end-stage renal disease patients, various abnormalities of bone mineral metabolism adversely affect mortality. Hyperphosphatemia is known to adversely affect mortality and quality of life in chronic kidney disease patients and has been shown to be
Autor:
Shintaro Yamanaka, Yuri Nakashima, Masaki Ohya, Toru Mima, Mari Moribata, Shigeo Negi, Asuka Masumoto, Takashi Shigematsu, Kouichi Tatsuta, Yuka Iwatani
In end-stage renal disease patients, various abnormalities of bone mineral metabolism adversely affect mortality. Hyperphosphatemia is known to adversely affect mortality and quality of life in chronic kidney disease patients and has been shown to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85186940940f7bb8675942c4bfc78cb5
https://doi.org/10.1159/000380969
https://doi.org/10.1159/000380969
Publikováno v:
Nihon Jinzo Gakkai shi. 55(4)